05-06-2009: Dako, Reagent Partnership Division, has entered into a five-year agreement with Fisher HealthCare, a division of Thermo Fisher Scientific. Under this agreement, Fisher Healthcare has been granted the exclusive right to distribute Flow Cytometry reagents in the US acute care market, including hospitals and reference labs.
Christian Kjaer, Vice President, Reagent Partnership Division of Dako, said: "We are delighted to be partnering with Fisher HealthCare to bring outstanding customer service to our customers along with a broad portfolio of world-class product solutions. The agreement furthers Dako's commitment to the growing cancer diagnostics market by strengthening and enlarging the Dako sales channel."
Mark Smits, Vice President, Marketing of Fisher HealthCare, said: "This partnership broadens our cancer-based diagnostic portfolio and allows us to provide a more comprehensive product offering to our customers. We will be better positioned to meet the needs of this market by capitalizing on Dako's long history of quality Flow Cytometry reagents and commitment to the diagnostic market."
Agilent Technologies Inc. and EQT, the Sweden-based private equity group, announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based cancer diagnostic company. The $2.2 billion acquisition (on a debt-free basis) is the largest in Agilent’s history.
“In ... more
Dako Denmark A/S and Epitomics, Inc. announced that they have entered into a collaboration which will allow the companies to unite competencies to provide the Anatomic Pathology market with state-of-the-art antibodies.Dako's expertise within the field of human cancer diagnostics, including ... more
Dako announced that two of its products have obtained a CE-mark as diagnostic tests for selecting patients with metastatic stomach (gastric) cancer who may benefit from Herceptin(TM) treatment. Dako's HercepTest(TM) and HER2 FISH pharmDx(TM) enable physicians to identify the unique group of ... more
Thermo Fisher Scientific announced a new approach using high-performance anion-exchange (HPAE) chromatography with pulsed amperometric detection (PAD) for the determination of carbohydrates in extracts from instant coffee and green coffee beans. Application Note 280: "Carbohydrate in Coffee ... more
Thermo Fisher Scientific Inc announced the 50th anniversary of its Maybridge chemistry products, a line of bioactive molecules to accelerate drug discovery and development. The Maybridge line is a comprehensive range of drug-like molecules and compound libraries for traditional drug-discov ... more
Thermo Fisher Scientific Inc. announced that it has been awarded a patent by the United States Patent and Trademark Office on its Thermo Scientific Nunc Cell Factory System with Active Gassing, recognizing the device’s unique gas distribution system. Developed for cells that require a high ... more
ENABLING OUR CUSTOMERS TO MAKE THE WORLD HEALTHIER, CLEANER AND SAFER
Thermo Scientific specializes in high-end analytical instruments, lab equipment, software, attendance, accessories and reagents as well as offering complete solutions for the integrated workflow. This enables us to offer ... more